|
|
Volumn 17, Issue 4, 2011, Pages 372-380
|
|
Evaluation of methylene blue, thiamine, and/or albumin in the prevention of ifosfamide-related neurotoxicity
a,b
|
|
Author keywords
albumin; encephalopathy; Ifosfamide; methylene blue; neurotoxicity; prophylaxis; thiamine
|
|
Indexed keywords
ALBUMIN;
ANTICONVULSIVE AGENT;
ANTIHISTAMINIC AGENT;
APREPITANT;
BENZODIAZEPINE;
DEXAMETHASONE;
DRONABINOL;
IFOSFAMIDE;
MESNA;
METHYLENE BLUE;
METOCLOPRAMIDE;
MUSCLE RELAXANT AGENT;
ONDANSETRON;
OPIATE;
PHENOTHIAZINE;
THIAMINE;
ADULT;
CLINICAL ARTICLE;
CLINICAL FEATURE;
COMORBIDITY;
CONTROLLED STUDY;
COST EFFECTIVENESS ANALYSIS;
DRUG COST;
FEMALE;
HEMORRHAGIC CYSTITIS;
HUMAN;
INCIDENCE;
MALE;
MULTIPLE CYCLE TREATMENT;
NEUROTOXICITY;
OUTCOME ASSESSMENT;
PRIORITY JOURNAL;
PROPHYLAXIS;
RETROSPECTIVE STUDY;
REVIEW;
RISK FACTOR;
RISK REDUCTION;
SARCOMA;
STATISTICAL SIGNIFICANCE;
VOMITING;
ADULT;
DRUG EVALUATION;
DRUG THERAPY, COMBINATION;
HUMANS;
IFOSFAMIDE;
METHYLENE BLUE;
MIDDLE AGED;
NEUROTOXICITY SYNDROMES;
RETROSPECTIVE STUDIES;
SERUM ALBUMIN;
THIAMINE;
|
|
EID: 82555171615
PISSN: 10781552
EISSN: 1477092X
Source Type: Journal
DOI: 10.1177/1078155210385159 Document Type: Review |
|
Times cited : (48)
|
|
References (11)
|
